Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating biliary cirrhosis

A technology of biliary cirrhosis and composition, applied in the field of medicine, can solve problems such as poor prognosis, few methods, and unsatisfactory curative effect

Inactive Publication Date: 2015-08-12
张天义
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The clinical manifestations of PBC are complex and diverse, and there are few simple western medicine treatments with unsatisfactory curative effects and poor prognosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

experiment example

[0018] Diagnostic criteria

[0019] Refer to the 2000 American Society for Liver Diseases (ASSLD) PBC diagnosis to specify (Heathcote EJ Managament of primary biliary cirrhosis The American Association for the Study of Liver Diseases Puactice Guideline Hepatology [J] 2000, 31: 1005-1013.). ①Cholestasis-related biochemical indicators such as elevated alkaline phosphatase (ALP); ②B-ultrasound or cholangiography showed normal bile ducts; ③Serum anti-mitochondrial antibody (AMA) or AMA-M subtype 2 was positive; ④Serum AMA / AMA -M 24 negative, liver biopsy pathology consistent with PBC. It can be diagnosed if it meets ①+②+③ or ①+②+④.

[0020] Select 52 patients who meet the above criteria, including 30 males and 22 females, aged 31-59 years. The average age is 39 years old. Clinical manifestations: pain in the liver area, anorexia, abdominal distension, fatigue, skin itching, joint pain, jaundice, hepatosplenomegaly, ascites, and edema of lower extremities. No serious diseases s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to pharmaceutical composition for treating biliary cirrhosis. The pharmaceutical composition comprises, by weight, 50-100 parts of ligustrum quihoui, 50-80 parts of pilea plataniflora, 50-70 parts of dracontomelon duperreanum, 50-100 parts of limonium bicolor, 30-80 parts of assorted Chinese herbal tea, 40-70 parts of sword bean, 50-100 parts of water hyacinth, 30-80 parts of tropaeolum majus, 30-70 parts of bredia amoena, 30-60 parts of broussonetia kazinoki, 30-50 parts of winter jasmine, 30-50 parts of diospyros lotus, 40-60 parts of honeysuckle stem, 30-50 parts of chrysopogon aciculatus, 40-70 parts of obscured homalomenarhizome, 40-50 parts of bauhinia championii, 30-70 parts of juniperus formosana hayata, 30-50 parts of white strawberry, 30-60 parts of lily and 40-50 parts of licorice. The pharmaceutical composition has the advantages that the medicines are matched and fitted, and the pharmaceutical composition is reasonable in component, capable considering the root causes and the symptoms, definite in curative effect, safe and convenient, free of toxic and side effects and cheap.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a pharmaceutical composition for treating biliary cirrhosis. Background technique [0002] Primary biliary cirrhosis (PBC) is a systemic immune disease involving multiple organs. Due to long-term persistent intrahepatic cholestasis, it causes liver fibrosis, cirrhosis and eventually liver failure. The clinical manifestations of PBC are complex and diverse, and there are few and unsatisfactory curative effects of simple western medicine treatment, and the prognosis is poor. Contents of the invention [0003] The object of the present invention is to provide a pharmaceutical composition for treating biliary cirrhosis. [0004] In order to realize the object of the present invention, the present invention provides a kind of pharmaceutical composition for the treatment of biliary liver cirrhosis, and it is made by weight of following crude drug: water white wax 50-100 parts, Shijincao 50-8...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61P1/16
Inventor 张天义
Owner 张天义
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products